Eleven invests in the Greek biotech company BIOPIX-T

After the initial investment from Metavallon.vc, we are exited to be also included in the portfolio of Eleven Ventures, further broadening the institutional support we receive and our geographical footprint!

On the investment in BIOPIX-T Valeri Petrov, Partner at Eleven Ventures explains: “BIOPIX-T is our first investment in Greece and the company fits perfectly in one of our four focus areas – Healthcare. We are very happy to welcome the strong founding team to the Eleven family. They have a spectacular scientific background and track record supported by and closely cooperating with leading international institutes and organisations in the field. The product is truly innovative and is responding to a long pending need for portable molecular diagnostic devices that could produce lab quality results at the point-of-care. The BIOPIX-T diagnostic platform is coming right on time, much ahead of the competition in terms of both technological advantages and commercialization. 

We are very happy to be co-investing alongside Metavallon VC as a trusted partner and one of the most prominent VC’s in Greece.